Physician profile
Chitra Chitale
NPI 1962728980
$317.85
in general payments reported to CMS, 2019-2025
8 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.18 · 2024: $40.60 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $317.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $127.40 | 2025 | |
| Astellas Pharma US INC | $63.85 | 2025 | Veozah |
| Scilex Pharmaceuticals INC. | $31.79 | 2025 | |
| Fresenius USA Marketing, INC. | $21.10 | 2024 | Velphoro |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.96 | 2025 | Relistor |
| Ardelyx, INC. | $19.50 | 2024 | Ibsrela |
| Glaxosmithkline, LLC. | $18.07 | 2025 | Trelegy Ellipta |
| Coopersurgical, INC. | $15.18 | 2023 | Summit Doppler |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chitra Chitale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.